TrialBritish journal of cancer2023

Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms.

Siren Morken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.